$5.360
-0.088 (-1.65%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AVIR Prediction & Forecast by Similar Chart Analysis
Alphio's AVIR stock price prediction model matches the current Atea Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.29 (-1.38%). The 1-week path is $5.17 (-3.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Atea Pharmaceuticals, Inc. Stock?
Atea Pharmaceuticals Inc is a good buy right now, trading at $5.36 with a recent RSI of 50.53 indicating neutral momentum. The stock has shown a significant year-to-date change of +54.02%, suggesting strong upward movement. Additionally, the company has completed patient enrollment in a key Phase 3 trial, which could lead to positive future developments and market opportunities. The main risk is its negative earnings trend, with a projected EPS of -0.41 for the last quarter, which may impact investor sentiment.
AVIR stock price ended at $5.36 on Friday, after losing -1.65%
Atea Pharmaceuticals, Inc. (AVIR) last closed at $5.36, losing -1.65%. These facts feed the 1-day and 1-week AVIR price prediction above.
Forecast Drivers
Atea Pharmaceuticals, Inc. (AVIR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches AVIR, ranked by similarity.
Seasonality analysis for AVIR
Historically the probability of a positive August return for AVIR is 96.83%. August offers the highest probability of a positive month at 96.83%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AVIR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.76 | $3.91 | $4.18 | -27.05% |
| Sep 2026 | $3.75 | $4.06 | $4.41 | -24.31% |
| Oct 2026 | $3.37 | $3.37 | $3.62 | -37.09% |
| Nov 2026 | $3.95 | $4.06 | $4.59 | -24.31% |
| Dec 2026 | $3.53 | $3.58 | $4.03 | -33.25% |
In 2026, Atea Pharmaceuticals, Inc. (AVIR) is projected to range from $3.37 to $4.59.
Atea Pharmaceuticals, Inc. 2026 monthly forecast
In Aug 2026, Atea Pharmaceuticals, Inc. is projected to average $3.91, with a low of $3.76 and high of $4.18.
In Sep 2026, Atea Pharmaceuticals, Inc. is projected to average $4.06, with a low of $3.75 and high of $4.41.
In Oct 2026, Atea Pharmaceuticals, Inc. is projected to average $3.37, with a low of $3.37 and high of $3.62.
In Nov 2026, Atea Pharmaceuticals, Inc. is projected to average $4.06, with a low of $3.95 and high of $4.59.
In Dec 2026, Atea Pharmaceuticals, Inc. is projected to average $3.58, with a low of $3.53 and high of $4.03.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.